Representative Carlos Curbelo is sounding off on Attorney General Jeff Sessions and calling for him to get out of the way of Medical Marijuana research.
Curbelo is asking Sessions to allow companies to research how Tetrahydrocannabinol (THC) and Cannabidiol (CBD) as the DEA has approved Tilray, a company based out of British Columbia, to import THC and CBD for studies covering nerve pain treatment.
Representative Curbelo explained that “Allowing a Canadian company to do what American companies are still waiting on the Department of Justice to grant them permission to do is incomprehensible. The United States has countless companies, including several in my home state of Florida, that are well-equipped to provide high quality cannabis extracts, but they are being roadblocked by Attorney General Jeff Sessions’ senseless witch hunt against an entire industry of legal, state-regulated small businesses.”
He also added that “With this announcement, the attorney general and the Department of Justice’s arcane prohibition on researching the effects of cannabis are now complicit in shipping American jobs and dollars abroad.”
Finally, Curbelo concluded that “Congress can and must act. I’m pleased that just last week the House Judiciary Committee passed H.R.5634, the Medical Cannabis Research Act, of which I am a proud cosponsor, to require the Justice Department to issue at least two more licenses to U.S. facilities to grow cannabis for research. I am hopeful that this bill will be considered on the House floor as soon as possible, and I urge my colleagues to support its passage. American jobs are at stake.”